NAAA
CRL icon

New Age Alpha Advisors’s Charles River Laboratories CRL Stock Holding History

New Age Alpha Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,433
Closed -$850K – 794
2025
Q3 		$850K Sell
5,433
-79
-1% -$12.5K 0.04% 439
2025
Q2 		$836K Sell
5,512
-5,276
-49% -$704K 0.04% 434
2025
Q1 		$1.62M Sell
10,788
-7,789
-42% -$1.31M 0.07% 350
2024
Q4 		$3.43M Buy
+18,577
New +$3.58M 0.14% 208

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

New Age Alpha Advisors's CRL Position: Q4 2025 in Review

New Age Alpha Advisors sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 5,433 shares — an estimated $850K sold.

New Age Alpha Advisors first reported a position in CRL in Q4 2024 and held it in 4 quarters. The position peaked at $3.43M in Q4 2024. 582 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • New Age Alpha Advisors reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • New Age Alpha Advisors sold 5,433 Charles River Laboratories shares in Q4 2025, an estimated $850K.
  • New Age Alpha Advisors first reported a position in Charles River Laboratories in Q4 2024 and held it in 4 quarters.
  • New Age Alpha Advisors's Charles River Laboratories position peaked at $3.43M in Q4 2024.
  • 582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on New Age Alpha Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.